SecSonar.com

Adagene Inc. (ADAG)

Adagene Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Adagene Inc. (ADAG) is a Biotechnology company based in CN with a market capitalization of $152.5M. Revenue grew 7332.8% year-over-year and free cash flow was negative at -$15.7M. This page tracks ADAG's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CN · 138 employees · IPO Feb 9, 2021

Valuation

Valuation & price

$3.67 · as of May 26, 2026 · -23.2% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

4.31

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$4.47$3.02$1.58Jul 25Dec 25Jul 26Jul 7, 25$1.95Jul 9, 25$1.88Jul 11, 25$1.91Jul 15, 25$1.90Jul 17, 25$1.69Jul 21, 25$1.93Jul 23, 25$1.93Jul 25, 25$1.99Jul 29, 25$1.99Jul 31, 25$1.99Aug 4, 25$1.91Aug 6, 25$2.37Aug 11, 25$2.29Aug 13, 25$1.65Aug 15, 25$1.69Aug 19, 25$1.96Aug 21, 25$2.28Aug 25, 25$2.35Aug 27, 25$2.19Aug 29, 25$2.13Sep 3, 25$2.18Sep 5, 25$2.20Sep 9, 25$2.50Sep 11, 25$2.34Sep 16, 25$2.13Sep 18, 25$2.07Sep 22, 25$2.01Sep 24, 25$2.03Sep 26, 25$1.96Sep 30, 25$1.99Oct 2, 25$1.94Oct 6, 25$1.99Oct 8, 25$1.96Oct 10, 25$1.95Oct 14, 25$1.84Oct 16, 25$1.78Oct 21, 25$1.89Oct 23, 25$1.79Oct 27, 25$1.85Oct 29, 25$1.84Oct 31, 25$1.78Nov 4, 25$1.70Nov 6, 25$1.61Nov 10, 25$1.58Nov 12, 25$1.77Nov 14, 25$1.83Nov 18, 25$1.98Nov 20, 25$1.77Nov 25, 25$1.99Nov 28, 25$2.01Dec 2, 25$1.99Dec 4, 25$1.97Dec 8, 25$1.99Dec 10, 25$1.81Dec 12, 25$1.75Dec 16, 25$1.90Dec 18, 25$1.83Dec 22, 25$1.88Dec 24, 25$1.85Dec 29, 25$1.79Jan 2, 26$1.84Jan 6, 26$1.82Jan 8, 26$1.65Jan 12, 26$1.59Jan 14, 26$1.80Jan 16, 26$1.96Jan 21, 26$1.69Jan 23, 26$2.49Jan 27, 26$2.49Jan 29, 26$2.91Feb 2, 26$2.94Feb 4, 26$2.84Feb 9, 26$2.67Feb 11, 26$3.10Feb 13, 26$3.25Feb 18, 26$3.29Feb 20, 26$3.14Feb 24, 26$3.35Feb 26, 26$3.11Mar 2, 26$2.96Mar 4, 26$2.93Mar 6, 26$2.84Mar 10, 26$2.93Mar 12, 26$3.56Mar 17, 26$3.91Mar 19, 26$3.69Mar 23, 26$3.92Mar 25, 26$4.07Mar 27, 26$3.77Mar 31, 26$3.92Apr 2, 26$3.99Apr 7, 26$4.43Apr 9, 26$3.85Apr 13, 26$3.84Apr 15, 26$3.82Apr 17, 26$3.97Apr 22, 26$3.78Apr 24, 26$3.69Apr 28, 26$3.53Apr 30, 26$3.68May 4, 26$3.66May 6, 26$3.61May 8, 26$3.69May 12, 26$3.66May 14, 26$3.66May 18, 26$3.39May 20, 26$3.45May 22, 26$3.75May 28, 26$3.94Jun 1, 26$3.78Jun 3, 26$3.46Jun 5, 26$3.32Jun 9, 26$3.40Jun 11, 26$3.58Jun 15, 26$3.64Jun 17, 26$3.53Jun 22, 26$3.84Jun 24, 26$4.25Jun 26, 26$4.19Jul 2, 26$4.47
$1.4152-week range$4.78
Loading valuation history…

Fundamentals

Key fundamentals

$152.5M

Market cap

7332.8%

Revenue growth (YoY)

100.0%

Gross margin

-$15.7M

Free cash flow (USD)

-$68.3M

Net debt

Net cash position

4.8%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$1.5MFY 2019$480.0KFY 2020$480.0KFY 2021$10.2MFY 2022$9.3MFY 2023$18.1MFY 2024$103.2KFY 2025$7.7M
$1.5M$7.7M

Free cash flow by year

2018 → 2025

FY 2018$-14.8MFY 2019$-18.3MFY 2020$-29.5MFY 2021$-45.9MFY 2022$-49.3MFY 2023$-28.5MFY 2024$-29.7MFY 2025$-15.7M
-$14.8M-$15.7M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 2024-797.5%FY 2025100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed Apr 2, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingData Presentation at AACRApr 17, 2026Filing
  • Annual reportAnnual Report FiledApr 2, 2026Filing
  • 6-K filingUnderwriting AgreementApr 2, 2026Filing
  • Annual reportAnnual Report FiledApr 1, 2026Filing
  • Annual report20-F FiledApr 1, 2026Filing

Questions

Frequently asked questions

What is Adagene Inc.'s market cap?

Adagene Inc. (ADAG) has a market capitalization of $152.5M.

What is ADAG's P/E ratio?

A meaningful P/E ratio is not available for ADAG — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ADAG's price-to-book (P/B) ratio?

ADAG trades at 4.31 times book value per share.

Are insiders buying ADAG stock?

SEC Form 4 filings show no open-market insider buys at Adagene Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

IVVD

Invivyd, Inc.

$151.3M

CNTB

Connect Biopharma Holdings Limited

$151.1M

MOLN

Molecular Partners AG

$148.2M

MDWD

MediWound Ltd.

$157.8M

UNCY

Unicycive Therapeutics, Inc.

$158.6M

VXRT

Vaxart, Inc.

$159.3M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.